Gen-AI is a massive tailwind for our business; expect to improve on industry growth rate of 12%: IKS Health Management
IKS Health, a healthcare platform serving 18% of US physicians, projects exceeding the industry's 12% growth rate. They aim for 30%+ EBITDA margins within two years, driven by tech leverage and the AQuity acquisition. Confident in long-term growth, they emphasize a large total addressable market and the potential of generative AI.
Заголовки